Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Changchun High-Tech Industry (Group) Co's annualized ROCE % for the quarter that ended in Jun. 2026 was 3.22%.
Changchun High-Tech Industry (Group) Co (SZSE:000661) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Changchun High-Tech Industry (Group) Co ROCE % Related Terms
Changchun High-Tech Industry (Group) Co ROCE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Changchun High-Tech Industry (Group) Co ROCE % Chart
Changchun High-Tech Industry (Group) Co Annual Data
(1) Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Changchun High-Tech Industry (Group) Co (SZSE:000661) has a ROCE % of 3.22% as of Jun. 2026.
Is Changchun High-Tech Industry (Group) Co's ROCE % too high?
Changchun High-Tech Industry (Group) Co's current ROCE % is 3.22%. The Drug Manufacturers industry median ROCE % is 6.57. Changchun High-Tech Industry (Group) Co's value of 3.22% is 51% below this industry median. Overall, Changchun High-Tech Industry (Group) Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Changchun High-Tech Industry (Group) Co's ROCE % compare to ZTS?
Changchun High-Tech Industry (Group) Co's ROCE % of 3.22% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 6.57. Changchun High-Tech Industry (Group) Co's value of 3.22% is 51% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 6.57, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Changchun High-Tech Industry (Group) Co's current ROCE % of 3.22% is 51% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 6.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Changchun High-Tech Industry (Group) Co's current ROCE % is 3.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Changchun High-Tech Industry (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Changchun High-Tech Industry (Group) Co (SZSE:000661) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥85.96, compared to a current price of ¥74.76 — trading 13% below its estimated fair value. The current ROCE % is 3.22% and 51% below the Drug Manufacturers industry median of 6.57. Changchun High-Tech Industry (Group) Co's overall GF Score™ is 84/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Changchun High-Tech Industry (Group) Co (SZSE:000661), the current ROCE % is 3.22% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Changchun High-Tech Industry (Group) Co (SZSE:000661) Overvalued in 2026?
Based on GuruFocus' analysis, Changchun High-Tech Industry (Group) Co stock appears to be undervalued.
The current stock price of ¥74.76 is trading 13% below its estimated GF Value™ of ¥85.96.
GuruFocus considers Changchun High-Tech Industry (Group) Co to be Modestly Undervalued.
Key valuation signals for SZSE:000661:
ROCE %: 3.22%
GF Value™: ¥85.96 vs. price of ¥74.76 (13% below fair value)
Industry Position: 51% below the Drug Manufacturers median
No single metric tells the full story. See the SZSE:000661 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Changchun High-Tech Industry (Group) Co Ltd is engaged in the production and sales of biopharmaceuticals, Chinese patent medicine production, and real estate development. The company operates its business through three segments. The Pharmaceuticals segment focuses on the research and development, manufacturing, and sales of genetically engineered biologics, human vaccines, traditional Chinese medicines, and chemical pharmaceuticals. The Real Estate segment is involved in property development and sales. The Services segment provides scientific research and technical support, along with leasing and various business-related services. It generates the majority of its revenue from the Pharmaceuticals segment.
84GF Score
Get the complete analysis for SZSE:000661
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000661 has been successfully added to your 
